Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Steroid 5-alpha-reductase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1093 | 0.6163 | 0.6163 |
Onchocerca volvulus | 0.0865 | 0.4355 | 0.7 | |
Echinococcus granulosus | tissue type plasminogen activator | 0.0366 | 0.0407 | 0.0407 |
Schistosoma mansoni | hypothetical protein | 0.0366 | 0.0407 | 0.0407 |
Brugia malayi | Protein kinase domain containing protein | 0.0366 | 0.0407 | 0.0274 |
Leishmania major | hypothetical protein, conserved | 0.0366 | 0.0407 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1578 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.1578 | 1 | 1 |
Echinococcus granulosus | laminin | 0.0332 | 0.0137 | 0.0137 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0366 | 0.0407 | 0.0407 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.1578 | 1 | 1 |
Schistosoma mansoni | egf-like domain protein | 0.0332 | 0.0137 | 0.0137 |
Onchocerca volvulus | 0.0366 | 0.0407 | 0.0448 | |
Onchocerca volvulus | 0.1093 | 0.6163 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.1093 | 0.6163 | 0.611 |
Echinococcus granulosus | carboxylesterase 5A | 0.1578 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.1578 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.1578 | 1 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.1578 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.1578 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1093 | 0.6163 | 0.6163 |
Echinococcus multilocularis | acetylcholinesterase | 0.1578 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.1578 | 1 | 1 |
Echinococcus multilocularis | laminin | 0.0332 | 0.0137 | 0.0137 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0366 | 0.0407 | 0.0274 |
Toxoplasma gondii | PAN domain-containing protein | 0.1039 | 0.5736 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.1578 | 1 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.1039 | 0.5736 | 1 |
Echinococcus multilocularis | fibrillin 1 | 0.0332 | 0.0137 | 0.0137 |
Loa Loa (eye worm) | hypothetical protein | 0.1578 | 1 | 1 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0332 | 0.0137 | 0.0137 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0366 | 0.0407 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0345 | 0.0236 | 0.0101 |
Loa Loa (eye worm) | hypothetical protein | 0.0366 | 0.0407 | 0.0274 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0366 | 0.0407 | 0.5 |
Brugia malayi | Trypsin family protein | 0.1093 | 0.6163 | 0.611 |
Loa Loa (eye worm) | hypothetical protein | 0.1093 | 0.6163 | 0.611 |
Echinococcus granulosus | Tolloid protein 1 | 0.0332 | 0.0137 | 0.0137 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0366 | 0.0407 | 0.5 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0332 | 0.0137 | 0.0137 |
Brugia malayi | Kringle domain containing protein | 0.0366 | 0.0407 | 0.0274 |
Toxoplasma gondii | kringle domain-containing protein | 0.0366 | 0.0407 | 0.0482 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 11 nM | Inhibition of Steroid 5-alpha-reductase from Dawley rat prostate | ChEMBL. | 10386934 |
IC50 (binding) | = 11 nM | Inhibition of Steroid 5-alpha-reductase from Dawley rat prostate | ChEMBL. | 10386934 |
pA2 (functional) | = 7.8 | Antagonistic Alpha-1 adrenergic receptor activity against phenylephrine-induced contraction of rabbit prostrate | ChEMBL. | 10386934 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.